skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi 5i, BNGO
This company is not currently in your data base. I am considering a 1/2 or 1/4 position is this genomics company and would like your opinion on 2- 3 year hold.
Is this a company you would have any interested in at the current price. Why/why not.
Any suggestions for similar strong candidates in this space.
Thx
Jim
Read Answer Asked by jim on February 17, 2021
Q: I was bullish on this for some time because the Ontario Gov't paid them to develop expanded, locally produced lab products, including but not limited to COVID and other testing reagents and VTM.
My fear was that a cheap, rapid test would make their COVID line irrelevant, but variants may be just the thing to keep their more technical tests relevant long-term.
How would you now view their risk/return as I want to add to my small 1% position?
Read Answer Asked by Darren on February 17, 2021
Q: I thought CVS was a reasonably good value at or below its recent price in the mid-70 dollars. It reported results today February 16, and tumbled ~ 5%. Before release of those latest results, I had calculated ROE just under 15% and PEG at ~2.4. (1) Do you have updates to key metrics, in addition to the above-noted ones (incorporating the latest results). (2) CVS’ acquisition of Aetna did cause indigestion, but I thought things were much better now. Not so? (3) I had also thought CVS’ participation in the administration of vaccines would very likely enhance impulse sales also. I am wrong on that too? ( So far, I am scoring zero out of 10, yes?)

Am I wrong about CVS? If it is not worth adding to my position, should I sell or leave my half position in peace for now and just monitor?
Read Answer Asked by Adam on February 17, 2021
Q: Do you see a upside potential in these companies, i.e doubling of stock from their current positions ?
Read Answer Asked by SAMAR on February 16, 2021
Q: Lost faith in CEO & his declaration that GUD is for grandchildren while the world is moving faster & faster.He is living on his past success.As a comparsion Well is making acquistions after acquistion, the latest being CRH,which is considered very beneficial. Has a 3% position in my TFSA bought many moons ago @ $10.16 incurring a44.6% loss.My thinking to sell it, if no catalyst in the horizon ,to buy better potential growth companies like ARKK &/or CURI.Still has 1% in non-registered a/c. Your comments.Thanks for u usual great services & views
Read Answer Asked by Peter on February 16, 2021
Q: As I type this question ILMN is up 13.68% today. I believe they reported yesterday so they must have been strong numbers. I'm thinking of selling my PFE to buy ILMN because (not including dividends) I'm slightly negative with PFE over 3 years. I know you like ILMN and I would be buying a higher risk company and cutting back the dividends but ILMN just seems an excellent company. It would be about a 2% weighting. Any comments would be appreciated.
Regards,
Jim
Read Answer Asked by James on February 12, 2021
Q: You have not fallen out of love with PFE. Neither had I , but my feelings for it have been getting very wobbly lately. I have had PFE for many years and still show a loss. Shares continue to decline, now at a faster rate it seems. Although several PFE drugs are going off patent , but I understand PFE has a good pipeline of promising new drugs. Is this why you love it so? Nevertheless, I would now admit defeat were it not for your very positive view of the company, which has encouraged my already biased positive regard. I am however now running out of excuses for holding on to this otherwise great company. I would therefore love to know what YOU regard are the catalysts for PFE going forward. Those catalysts seems to be things I have missed completely.
Read Answer Asked by Adam on February 12, 2021
Q: GMDA Positive results ! Have a Jumbo position. Sell or Hold ? Thanks
Read Answer Asked by Kamal on February 10, 2021
Q: 5i,

A bit more information for Yves question on WELL. The following from an RBC note on CRH may be the major concern.

“Uncertainty regarding potential loss of largest customer. In December 2020, CRH disclosed that its largest customer (United Digestive, guided to contribute ~20% of 2021 Adj. EBITDA to SH) doesn't intend to renew its service agreement with CRH, which would negatively impact CRH's results beginning in 2022. Negotiations are continuing.”

Read Answer Asked by John on February 09, 2021
Q: Hi 5i - I understand that WELL is a provider of OSCAR electronic medical records, with this open source software originally developed by McMaster University. Today I see that Alphabet is filing for a new IPO, OSCAR Health which aims to cash in on the surge for digital health services. Is there any connection between WELL and Alphabet on this or perhaps it's Alphabet tapping into the OSCAR open source software?
Read Answer Asked by Martha on February 09, 2021
Q: Hi 5i - I have very small positions in CRH, CZO and RHT. I was thinking of selling them and using the proceeds to buy a 2-3% position in WELL. Good plan, or would you keep any of the stocks listed?

Thanks, Neil
Read Answer Asked by Neil on February 09, 2021
Q: Hi I would like your opinion on VERU?

Thanks
Read Answer Asked by Stephane on February 09, 2021
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!